Author

Clarisse Maurin

Institutions: St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, National Institute for Health and Care Research

Observed institutions: St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, National Institute for Health and Care Research

OpenAlex ID: A5031920751

Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa

2019 · Ellie Rashidghamat, Tendai Kadiyirire, et al. · Journal of the American Academy of Dermatology · 105

Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa

2019 · Su M. Lwin, Farhatullah Syed, et al. · JCI Insight · 93

Works count: 2

Citation count: 198

H-index: 2

I10-index: 2